Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.

Thumbnail
View / Open Files
Authors
Saarela, Mika
Senthil, Keerthi
Jones, Joanne
Tienari, Pentti J
Soilu-Hänninen, Merja
Airas, Laura
  Coles, Alasdair
Publication Date
2018-05-01
Journal Title
Neurology
ISSN
0028-3878
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
90
Issue
18
Pages
849-851
Language
eng
Type
Article
Physical Medium
Print-Electronic
Metadata
Show full item record
Citation
Saarela, M., Senthil, K., Jones, J., Tienari, P. J., Soilu-Hänninen, M., Airas, L., Coles, A., & et al. (2018). Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.. Neurology, 90 (18), 849-851. https://doi.org/10.1212/WNL.0000000000005420
Keywords
Adult, Alemtuzumab, Fatal Outcome, Female, Humans, Immunologic Factors, Lymphohistiocytosis, Hemophagocytic, Male, Multiple Sclerosis, Relapsing-Remitting
Sponsorship
Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
Wellcome Trust (105924/Z/14/Z)
Wellcome Trust (105924/Z/14/A)
Medical Research Council (G1100114)
Identifiers
External DOI: https://doi.org/10.1212/WNL.0000000000005420
This record's URL: https://www.repository.cam.ac.uk/handle/1810/285473
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics



Total file downloads (since January 2020). For more information on metrics see the IRUS guide.